Barinthus Biotherapeutics plc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Barinthus Biotherapeutics plc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Barinthus Biotherapeutics plc. Assets for the quarter ending September 30, 2024 was $189M, a 18% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$189M	-$41.3M	-18%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$187M	-$59.4M	-24.1%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$199M	-$62.3M	-23.8%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$215M	-$55.7M	-20.6%	Dec 31, 2023	10-Q	2024-11-06
Q3 2023	$230M	-$45.5M	-16.5%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$246M	-$38.9M	-13.7%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$262M	-$24.3M	-8.5%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$270M	-$10.5M	-3.74%	Dec 31, 2022	10-K	2024-03-20
Q3 2022	$275M	+$18.9M	+7.37%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$285M	+$25.2M	+9.71%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$286M	+$120M	+71.9%	Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$281M	+$230M	+454%	Dec 31, 2021	10-K	2023-03-24
Q3 2021	$257M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$260M			Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$166M			Mar 31, 2021	10-Q	2021-06-14
Q4 2020	$50.7M			Dec 31, 2020	10-K	2022-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.